deucravacitinib,apremilast
BMS,amgen
[]
wcd 2023 day 3 morning - oral and topical jak inhibitors dr. ronald b. vender gives insights into #jak and #tyk2 inhibitors at the #wcd2023 in #singapore 
Up-to-date clinical news for dermatology. Publishers of The Chronicle of Skin & Allergy, The Chronicle of Cosmetic Medicine & Surgery, & Skin Spectrum Summit